These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10680708)

  • 1. Effect of biscoclaurine alkaloids, prednisolone and ascorbic acid on myelodysplastic syndrome with pancytopenia: a case report.
    Saito N; Miyamoto M; Gotoh U; Yoshitomi S
    Eur J Haematol; 2000 Jan; 64(1):61-5. PubMed ID: 10680708
    [No Abstract]   [Full Text] [Related]  

  • 2. A case with pancytopenia: the role of cytomorphology.
    Sukrisman L; Mulansari NA; Sudoyo AW
    Acta Med Indones; 2013 Jan; 45(1):67-8. PubMed ID: 23585412
    [No Abstract]   [Full Text] [Related]  

  • 3. A myelodysplastic syndrome preceding acute lymphoblastic leukaemia.
    Berneman ZN; Van Bockstaele D; De Meyer P; Van der Planken M; Vertessen F; De Bock R; Peetermans ME
    Br J Haematol; 1985 Jun; 60(2):353-4. PubMed ID: 3859321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune pancreatitis associated with myelodysplastic syndrome.
    Tabata R; Tabata C; Okamoto T; Omori K; Terada M; Nagai T
    Int Arch Allergy Immunol; 2010; 151(2):168-72. PubMed ID: 19752571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical analysis of Sweet syndrome with myelodysplasia syndrome].
    Wang YN; Zhuang JL; Zhao WL; Fang K; Liu YH; Jin HZ; Li L
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1755-7. PubMed ID: 27356643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trilineage myelodysplasia and hemophagocytosis associated with systemic lupus erythematosus.
    Paliga A; Shahbazi N; Gonsalves C; Bormanis J; Padmore R
    Am J Hematol; 2012 May; 87(5):529-30. PubMed ID: 22038620
    [No Abstract]   [Full Text] [Related]  

  • 7. Distinct bone marrow morphologic features discriminate myelodysplastic syndromes patients with and without an early platelet response to decitabine.
    May AM; Stomper J; Joeckel TE; Bronsert P; Wijermans PW; Werner M; Lübbert M
    Br J Haematol; 2020 Jun; 189(5):e194-e197. PubMed ID: 32207144
    [No Abstract]   [Full Text] [Related]  

  • 8. Pregnancy-induced pancytopenia with cellular bone marrow: distinctive hematologic features.
    Natelson EA
    Am J Med Sci; 2006 Oct; 332(4):205-7. PubMed ID: 17031246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gaucher disease and myelodysplastic syndrome with isolated del(5q).
    Villarrubia J; Rodríguez-Gambarte JD; Abalo L; Vallés A; Alonso-Domínguez JM; Velasco-Rodríguez D
    Br J Haematol; 2014 Apr; 165(2):164. PubMed ID: 24611589
    [No Abstract]   [Full Text] [Related]  

  • 10. Coexistence of Sézary syndrome and dysmyelopoiesis with an excess of myeloblasts.
    Rostoker G; Raphael M; Boisnick S; Charron D
    J Am Acad Dermatol; 1986 Dec; 15(6):1296-8. PubMed ID: 3805369
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypoplastic myelodysplastic syndrome-a clinical, morphologic, or genetic diagnosis?
    Wong KF; So CC
    Cancer Genet Cytogenet; 2002 Oct; 138(1):85-8. PubMed ID: 12419592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical features of cytopenia with bone marrow hypoplasia in children: an analysis of 100 cases].
    Yang WY; Chen XJ; Zhang PH; Hama A; Ito M; Kojima S; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):448-52. PubMed ID: 23791060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow biopsy of aplastic anemia, myelodysplastic syndromes and myeloproliferative disorders.
    Kikuchi M
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1339-46. PubMed ID: 3247814
    [No Abstract]   [Full Text] [Related]  

  • 14. Significance of bone marrow sideroblastosis in myelodysplastic syndromes.
    Economopoulos T; Karakassis D; Stathakis N; Pappa V; Raptis S
    Eur J Haematol; 1990 Aug; 45(2):118-20. PubMed ID: 2209817
    [No Abstract]   [Full Text] [Related]  

  • 15. Pseudo-Chédiak-Higashi anomaly.
    Gallardo R; Kranwinkel RN
    Am J Clin Pathol; 1985 Jan; 83(1):127-9. PubMed ID: 3966432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelodysplastic syndrome and pancytopenia responding to treatment of hyperthyroidism: peripheral blood and bone marrow analysis before and after antihormonal treatment.
    Akoum R; Michel S; Wafic T; Emile B; Marwan M; Khaled H; Gerard A
    J Cancer Res Ther; 2007; 3(1):43-6. PubMed ID: 17998720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD41 immune staining of micromegakaryocytes improves the diagnosis of myelodysplastic syndrome and differentiation from pancytopenia.
    Huang J; Wang Z; Huang L; Zheng M
    Leuk Res; 2018 Mar; 66():15-19. PubMed ID: 29353154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of dysmyelopoietic/leukemic syndromes with myelofibrosis and megakaryocytic hyperplasia with large doses of cytosine arabinoside.
    Preisler HD; Raza A; Barcos M
    Med Oncol Tumor Pharmacother; 1985; 2(2):87-91. PubMed ID: 4058079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide in the treatment of myelodysplastic syndrome with fibrosis.
    Tsirigotis P; Venetis E; Rontogianni D; Dervenoulas J; Kontopidou F; Apostolidis P
    Leuk Res; 2002 Oct; 26(10):965-6. PubMed ID: 12163059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaplastic large-cell lymphoma which showed severe inflammatory status and myelodysplasia with increased VEGF and IL-6 serum levels after long-term immunosuppressive therapy.
    Shimamoto T; Hayashi S; Ando K; Yguchi M; Miyazawa K; Kimura Y; Mukai K; Serizawa H; Ohyashiki K
    Am J Hematol; 2001 Jan; 66(1):49-52. PubMed ID: 11426493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.